ADIPOQ and breast cancer: In addition to FAO and FAS, our preliminary findings also suggested that adiponectin decreases the expression of membrane lipid transporters, including CD36 and LDLR, which may further contribute to fatty acid depletion in breast cancer cells (Fig. S5).